These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 30863058

  • 21. Development and evaluation of a novel drug delivery: Soluplus®/TPGS mixed micelles loaded with piperine in vitro and in vivo.
    Ding Y, Wang C, Wang Y, Xu Y, Zhao J, Gao M, Ding Y, Peng J, Li L.
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1409-1416. PubMed ID: 29718714
    [Abstract] [Full Text] [Related]

  • 22. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P, Li L, Zhou S, Qiu L, Qian Z, Liu X, Cao X, Zhang H.
    Mater Sci Eng C Mater Biol Appl; 2018 Mar 01; 84():108-117. PubMed ID: 29519418
    [Abstract] [Full Text] [Related]

  • 23. A complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growth.
    Zhang D, Xu Q, Wang N, Yang Y, Liu J, Yu G, Yang X, Xu H, Wang H.
    Int J Nanomedicine; 2018 Mar 01; 13():4549-4561. PubMed ID: 30127606
    [Abstract] [Full Text] [Related]

  • 24. Induction of Mitochondrial Cell Death and Reversal of Anticancer Drug Resistance via Nanocarriers Composed of a Triphenylphosphonium Derivative of Tocopheryl Polyethylene Glycol Succinate.
    Singh Y, Viswanadham KKDR, Pawar VK, Meher J, Jajoriya AK, Omer A, Jaiswal S, Dewangan J, Bora HK, Singh P, Rath SK, Lal J, Mishra DP, Chourasia MK.
    Mol Pharm; 2019 Sep 03; 16(9):3744-3759. PubMed ID: 31441308
    [Abstract] [Full Text] [Related]

  • 25. TPGS-Galactose-Modified Polydopamine Co-delivery Nanoparticles of Nitric Oxide Donor and Doxorubicin for Targeted Chemo-Photothermal Therapy against Drug-Resistant Hepatocellular Carcinoma.
    Du Z, Mao Y, Zhang P, Hu J, Fu J, You Q, Yin J.
    ACS Appl Mater Interfaces; 2021 Aug 04; 13(30):35518-35532. PubMed ID: 34286569
    [Abstract] [Full Text] [Related]

  • 26. Targeted co-delivery of the aldose reductase inhibitor epalrestat and chemotherapeutic doxorubicin via a redox-sensitive prodrug approach promotes synergistic tumor suppression.
    Banala VT, Urandur S, Sharma S, Sharma M, Shukla RP, Marwaha D, Gautam S, Dwivedi M, Mishra PR.
    Biomater Sci; 2019 Jun 25; 7(7):2889-2906. PubMed ID: 31086900
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Solid lipid nanoparticles co-loaded with doxorubicin and α-tocopherol succinate are effective against drug-resistant cancer cells in monolayer and 3-D spheroid cancer cell models.
    Oliveira MS, Aryasomayajula B, Pattni B, Mussi SV, Ferreira LAM, Torchilin VP.
    Int J Pharm; 2016 Oct 15; 512(1):292-300. PubMed ID: 27568499
    [Abstract] [Full Text] [Related]

  • 30. Biocompatible cationic pullulan-g-desoxycholic acid-g-PEI micelles used to co-deliver drug and gene for cancer therapy.
    Chen L, Ji F, Bao Y, Xia J, Guo L, Wang J, Li Y.
    Mater Sci Eng C Mater Biol Appl; 2017 Jan 01; 70(Pt 1):418-429. PubMed ID: 27770912
    [Abstract] [Full Text] [Related]

  • 31. PEGylated phospholipid micelles containing D-α-tocopheryl succinate as multifunctional nanocarriers for enhancing the antitumor efficacy of doxorubicin.
    Jiang W, Fan Q, Wang J, Zhang B, Hao T, Chen Q, Li L, Chen L, Cui H, Li Z.
    Int J Pharm; 2021 Sep 25; 607():120979. PubMed ID: 34371151
    [Abstract] [Full Text] [Related]

  • 32. Nitric oxide releasing d-α-tocopheryl polyethylene glycol succinate for enhancing antitumor activity of doxorubicin.
    Song Q, Tan S, Zhuang X, Guo Y, Zhao Y, Wu T, Ye Q, Si L, Zhang Z.
    Mol Pharm; 2014 Nov 03; 11(11):4118-29. PubMed ID: 25222114
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S, Li M, Tang Z, Song W, Sun H, Liu H, Chen X.
    Acta Biomater; 2013 Dec 03; 9(12):9330-42. PubMed ID: 23958784
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol succinate and folic acid as a prodrug for targeted chemotherapy.
    Anbharasi V, Cao N, Feng SS.
    J Biomed Mater Res A; 2010 Sep 01; 94(3):730-43. PubMed ID: 20225211
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance.
    Wang J, Sun J, Chen Q, Gao Y, Li L, Li H, Leng D, Wang Y, Sun Y, Jing Y, Wang S, He Z.
    Biomaterials; 2012 Oct 01; 33(28):6877-88. PubMed ID: 22770799
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.